Alf Meem Yaa for Medical Supplies and Equipment Company (TADAWUL:9527)
70.30
+1.20 (1.74%)
Sep 3, 2026, 3:10 PM AST
TADAWUL:9527 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 314.29 | 304.96 | 248.35 | 220.01 | 193.17 | 151.39 | |
Revenue Growth | 13.72% | 22.80% | 12.88% | 13.90% | 27.60% | 24.49% |
Cost of Revenue | 176.48 | 176.48 | 146.19 | 124.57 | 102.89 | 81.84 |
Gross Profit | 137.82 | 128.49 | 102.16 | 95.45 | 90.28 | 69.54 |
Selling, General & Admin | 72.65 | 72.65 | 59.19 | 56.56 | 52.68 | 40.38 |
Other Operating Expenses | 7.5 | -2.71 | -4.63 | -4.11 | - | 4.45 |
Operating Expenses | 96.42 | 86.21 | 52.83 | 58.61 | 60.55 | 45.11 |
Operating Income | 41.4 | 42.28 | 49.33 | 36.84 | 29.73 | 24.44 |
Interest Expense | -2.27 | -2.27 | -0.17 | -0.21 | -0.1 | -0.17 |
Interest & Investment Income | 0.62 | 0.62 | - | - | - | - |
Currency Exchange Gain (Loss) | -0.83 | -0.83 | 0.89 | 0.95 | 0.41 | -0.06 |
Other Non Operating Income (Expenses) | -1.08 | -1.08 | - | - | - | - |
Pretax Income | 37.85 | 38.73 | 50.04 | 37.58 | 30.03 | 24.21 |
Income Tax Expense | 4.15 | 3.72 | 4.64 | 4.07 | 3.35 | 2.99 |
Net Income | 33.7 | 35.01 | 45.4 | 33.52 | 26.68 | 21.22 |
Net Income to Common | 33.7 | 35.01 | 45.4 | 33.52 | 26.68 | 21.22 |
Net Income Growth | -27.86% | -22.89% | 35.46% | 25.60% | 25.73% | 0.72% |
Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 7 | 7 |
Shares Outstanding (Diluted) | 7 | 7 | 7 | 7 | 7 | 7 |
Shares Change | 0.03% | - | - | - | 0.65% | 21.22% |
EPS (Basic) | 4.81 | 5.00 | 6.49 | 4.79 | 3.81 | 3.05 |
EPS (Diluted) | 4.81 | 5.00 | 6.49 | 4.79 | 3.81 | 3.05 |
EPS Growth | -27.89% | -22.89% | 35.46% | 25.60% | 24.93% | -16.91% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -7.01 | -26.78 | -3.9 | 34.72 | 7.56 | 19.93 |
Free Cash Flow Per Share | -1.00 | -3.83 | -0.56 | 4.96 | 1.08 | 2.87 |
Dividend Per Share | 2.000 | 2.000 | 2.000 | 2.000 | 2.000 | 1.750 |
Dividend Growth | 0% | 0% | 0% | 0% | 14.29% | - |
Gross Margin | 43.85% | 42.13% | 41.13% | 43.38% | 46.74% | 45.94% |
Operating Margin | 13.17% | 13.86% | 19.86% | 16.74% | 15.39% | 16.14% |
Profit Margin | 10.72% | 11.48% | 18.28% | 15.23% | 13.81% | 14.02% |
Free Cash Flow Margin | -2.23% | -8.78% | -1.57% | 15.78% | 3.91% | 13.16% |
EBITDA | 42.21 | 43.08 | 50.05 | 37.26 | 30.01 | 24.56 |
EBITDA Margin | 13.43% | 14.13% | 20.15% | 16.93% | 15.53% | 16.22% |
D&A For EBITDA | 0.81 | 0.8 | 0.72 | 0.42 | 0.28 | 0.12 |
EBIT | 41.4 | 42.28 | 49.33 | 36.84 | 29.73 | 24.44 |
EBIT Margin | 13.17% | 13.86% | 19.86% | 16.74% | 15.39% | 16.14% |
Effective Tax Rate | 10.96% | 9.60% | 9.28% | 10.82% | 11.15% | 12.34% |